Skip to main content
HCPCS J2791 · Level II · Part B drug

J2791: rho, HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J2791

Billing unit
100 IU
Rhophylac injection
ASP payment limit
$4.837
October 2026; -0.8% vs July 2026
Practitioner MUE
15
MAI 3
OPPS status
SI N
NCCI exposure
no PTP pairs
Coverage articles
2
6 states

TL;DR

HCPCS J2791 is the Level II code for Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu, billed per 100 IU. The Medicare Part B ASP payment limit for October 2026 is $4.837 per billing unit, down 0.8% from July 2026. The practitioner MUE allows up to 15 units per date of service (MAI 3), so a full 15-unit day is $72.55 at the current limit. Under OPPS it carries status indicator N. J2791 is billed in units of 100 IU; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. The ASP crosswalk maps 2 NDCs to it, sold as Rhophylac by CSL Behring L.L.C. 2 Medicare coverage articles list the code across 6 states, including A56718.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J2791 at $4.837 per 100 IU for October 2026, derived from manufacturer average sales price plus 6%, compared with $4.878 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J2791
QuarterPayment limitPerCoinsurance
October 2026$4.837100 IU20%
July 2026$4.878100 IU—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 2 NDCs from 1 labeler to J2791. Report the NDC in the claim's drug segment and bill the number of J2791 units that equals the quantity administered divided by 100 IU; the last column gives units per full package.

NDCs that crosswalk to J2791
NDCDrug nameLabelerPackage sizeBilling units / package
44206-0300-01RhophylacCSL Behring L.L.C.2 × 115
44206-0300-10RhophylacCSL Behring L.L.C.2 × 10150

Medically Unlikely Edits (MUE)

CMS publishes 2 MUE values for J2791. For practitioners the limit is 15 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J2791 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services153 Date of Service Edit: ClinicalClinical: Data
Facility outpatient hospital153 Date of Service Edit: ClinicalClinical: Data

MUE for J2791 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

Medicaid NCCI differs: the 2026 Q4 Medicaid MUE for J2791 is 50 units for practitioner claims (Medicare: 15) and 275 units for outpatient hospital claims (Medicare: 15). Compare both programs in the MUE lookup or read how Medicaid NCCI differs from Medicare.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J2791 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J2791 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J2791 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

2 current Medicare Administrative Contractor articles list J2791 in their HCPCS tables, covering 6 states. Each article carries the covered and non-covered ICD-10 codes that medical-necessity denials (CARC 50) are adjudicated against.

Billing and Coding Articles listing J2791
ArticleTitleContractor(s)StatesRelated LCD
A56718Billing and Coding: Intravenous Immunoglobulin (IVIG)Palmetto GBANC SC VA WVL34580
A57160Billing and Coding: Immune Thrombocytopenia (ITP) TherapyCGS Administrators, LLCKY OHL38268

Diagnoses Medicare contractors cover for J2791

2 billing and coding articles attach a covered diagnosis list to J2791: 212 distinct ICD-10-CM codes in all. The 15 below come first by how many of those articles cover them, then in the contractor's own order. The claim line is checked against the list of the contractor that processes it, and a diagnosis outside that list is denied as not medically necessary (CARC 50).

First 15 covered ICD-10-CM codes for J2791
ICD-10-CMDescription (FY2027)Articles covering
D69.3Immune thrombocytopenic purpura2 of 2
A85.8Other specified viral encephalitis1 of 2
B08.3Erythema infectiosum [fifth disease]1 of 2
B20Human immunodeficiency virus [HIV] disease1 of 2
B25.0Cytomegaloviral pneumonitis1 of 2
B25.1Cytomegaloviral hepatitis1 of 2
B25.2Cytomegaloviral pancreatitis1 of 2
B25.8Other cytomegaloviral diseases1 of 2
B25.9Cytomegaloviral disease, unspecified1 of 2
C88.00Waldenstrom macroglobulinemia not having achieved remission1 of 2
C90.00Multiple myeloma not having achieved remission1 of 2
C90.02Multiple myeloma in relapse1 of 2
C91.10Chronic lymphocytic leukemia of B-cell type not having achieved remission1 of 2
C91.11Chronic lymphocytic leukemia of B-cell type in remission1 of 2
C91.12Chronic lymphocytic leukemia of B-cell type in relapse1 of 2
197 more codes are in the full lists linked below.

Contractors split an article's diagnoses into numbered groups and say in each group's instructions which procedure codes it supports. Only the groups that apply to J2791 are counted here. The full list opens on the policy page with every group, the non-covered codes and the instructions.

Covered diagnosis lists that apply to J2791, by article
ArticleContractorGroups that applyCovered codes for J2791Full list
A56718Palmetto GBAone list for every code in the article212On LCD L34580
A57160CGS Administrators, LLCone list for every code in the article1On LCD L38268

Local coverage policies that list J2791

3 active Local Coverage Determinations list J2791 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J2791 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J2791 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.

Common denials for J2791 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J2791

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J2791

What does HCPCS code J2791 describe?

J2791 is defined by CMS as "Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu". Each billing unit represents 100 IU, so the units reported on the claim must equal the dose administered divided by that unit.

Is J2791 a CPT code?

No. J2791 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as rho; CPT codes are five-character codes maintained by the AMA. On a Part B claim J2791 reports the drug itself in 100 IU units, and the administration is billed on its own line.

What is the Medicare reimbursement for J2791 in October 2026?

The ASP-based payment limit is $4.837 per 100 IU, with 20% beneficiary coinsurance. The July 2026 limit was $4.878. Commercial payers use their own fee schedules.

How many units of J2791 can be billed per day?

The practitioner Medically Unlikely Edit is 15 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Clinical: Data" as the rationale.

Which NDCs map to J2791?

The October 2026 ASP crosswalk lists 2 NDCs from 1 labeler: Rhophylac (CSL Behring L.L.C.). For example NDC 44206-0300-01 (package size 2) equals 15 billing units of J2791.

Does J2791 have NCCI bundling edits?

No active practitioner PTP pairs list J2791 as a column-1 or column-2 code in the v323r0 release.

Which Medicare coverage articles mention J2791?

2 current Billing and Coding Articles in the Medicare Coverage Database list J2791, covering 6 states: A56718 (Billing and Coding: Intravenous Immunoglobulin (IVIG)); A57160 (Billing and Coding: Immune Thrombocytopenia (ITP) Therapy).

What diagnosis codes support J2791?

2 Medicare billing and coding articles list 212 covered ICD-10-CM codes for J2791 between them, for example D69.3 (Immune thrombocytopenic purpura); A85.8 (Other specified viral encephalitis); B08.3 (Erythema infectiosum [fifth disease]); B20 (Human immunodeficiency virus [HIV] disease); B25.0 (Cytomegaloviral pneumonitis). Each contractor's list applies only in its own jurisdiction, so the claim must carry a code from the article of the contractor that processes it.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.